|
| |
| | | 67648 | | 26.04.2021 | | Novartis Pharma Schweiz AG | | | | | | | 06.03.2028 | | | | | | 70000. | | | | 07.16.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Tabrecta 150 mg | Filmtabletten | Filmtabletten (Capmatinibum 150 mg) | L01EX17 | PI | | 02 | Tabrecta 200 mg | Filmtabletten | Filmtabletten (Capmatinibum 200 mg) | L01EX17 | PI |
|
|
|
